The cardiac component of cardiac cachexia

Viorel G. Florea, Michael Y. Henein, Mathias Rauchhaus, Veronika Koloczek, Rakesh Sharma, Wolfram Doehner, Philip A. Poole-Wilson, Andrew J S Coats, Stefan D. Anker

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Background: Recent evidence suggests the importance of noncardiac mechanisms in the genesis of the syndrome of cardiac cachexia. This raises the question of the relative role of the heart itself in this syndrome. This study sought to assess the cardiac dimensions, mass, and function and changes in these parameters over time in patients with chronic heart failure with and without cachexia. Methods: Doppler echocardiography was performed in 28 patients with nonedematous weight loss (>7.5% over a period of >6 months) compared with 56 matched patients without weight loss in a ratio of 1:2 (age 71 ± 13 vs 67 ± 8 years, P = .07; New York Heart Association class 2.9 ± 0.7 vs 2.6 ± 0.6, P = .08). In 18 cachectic and 35 noncachectic patients with previous echocardiographic recordings, we analyzed the changes in left ventricular (LV) dimensions and mass over time. Results: Cardiac dimensions including LV diastolic (69 ± 9 mm vs 67 ± 13 mm) and systolic cavity diameter (58 ± 11 mm vs 55 ± 15 mm), LV mass (480 ± 180 g vs 495 ± 190 g), and LV systolic and diastolic function including fractional shortening (16% ± 10% vs 18% ± 10%), isovolumic relaxation time (29 ± 22 ms vs 36 ± 27 ms), and E/A ratio (2.7 ± 1.6 vs 3.3 ± 2.9) did not differ between cachectic and noncachectic patients (all P > . 1). By analyzing changes in LV mass over time, we found an increase (>20%) in 2 (11%) cachectic and 14 (40%) noncachectic patients and a decrease in LV mass (>20%) in 9 (50%) cachectic and 8 (23%) noncachectic patients (x2 test, P <.05). Conclusions: Although no specific cardiac abnormality could be detected echocardiographically in cachectic patients compared with patients with noncachectic chronic heart failure in a cross-sectional study, over time a significant loss of LV mass (>20%) occurs more frequently in patients with cardiac cachexia.

Original languageEnglish
Pages (from-to)45-50
Number of pages6
JournalAmerican Heart Journal
Volume144
Issue number1
DOIs
Publication statusPublished - 2002

Fingerprint

Cachexia
Weight Loss
Doppler Echocardiography
Heart Failure

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Florea, V. G., Henein, M. Y., Rauchhaus, M., Koloczek, V., Sharma, R., Doehner, W., ... Anker, S. D. (2002). The cardiac component of cardiac cachexia. American Heart Journal, 144(1), 45-50. https://doi.org/10.1067/mhj.2002.123314

The cardiac component of cardiac cachexia. / Florea, Viorel G.; Henein, Michael Y.; Rauchhaus, Mathias; Koloczek, Veronika; Sharma, Rakesh; Doehner, Wolfram; Poole-Wilson, Philip A.; Coats, Andrew J S; Anker, Stefan D.

In: American Heart Journal, Vol. 144, No. 1, 2002, p. 45-50.

Research output: Contribution to journalArticle

Florea, VG, Henein, MY, Rauchhaus, M, Koloczek, V, Sharma, R, Doehner, W, Poole-Wilson, PA, Coats, AJS & Anker, SD 2002, 'The cardiac component of cardiac cachexia', American Heart Journal, vol. 144, no. 1, pp. 45-50. https://doi.org/10.1067/mhj.2002.123314
Florea VG, Henein MY, Rauchhaus M, Koloczek V, Sharma R, Doehner W et al. The cardiac component of cardiac cachexia. American Heart Journal. 2002;144(1):45-50. https://doi.org/10.1067/mhj.2002.123314
Florea, Viorel G. ; Henein, Michael Y. ; Rauchhaus, Mathias ; Koloczek, Veronika ; Sharma, Rakesh ; Doehner, Wolfram ; Poole-Wilson, Philip A. ; Coats, Andrew J S ; Anker, Stefan D. / The cardiac component of cardiac cachexia. In: American Heart Journal. 2002 ; Vol. 144, No. 1. pp. 45-50.
@article{8355f4f100234c318fa8a01f0d1371a6,
title = "The cardiac component of cardiac cachexia",
abstract = "Background: Recent evidence suggests the importance of noncardiac mechanisms in the genesis of the syndrome of cardiac cachexia. This raises the question of the relative role of the heart itself in this syndrome. This study sought to assess the cardiac dimensions, mass, and function and changes in these parameters over time in patients with chronic heart failure with and without cachexia. Methods: Doppler echocardiography was performed in 28 patients with nonedematous weight loss (>7.5{\%} over a period of >6 months) compared with 56 matched patients without weight loss in a ratio of 1:2 (age 71 ± 13 vs 67 ± 8 years, P = .07; New York Heart Association class 2.9 ± 0.7 vs 2.6 ± 0.6, P = .08). In 18 cachectic and 35 noncachectic patients with previous echocardiographic recordings, we analyzed the changes in left ventricular (LV) dimensions and mass over time. Results: Cardiac dimensions including LV diastolic (69 ± 9 mm vs 67 ± 13 mm) and systolic cavity diameter (58 ± 11 mm vs 55 ± 15 mm), LV mass (480 ± 180 g vs 495 ± 190 g), and LV systolic and diastolic function including fractional shortening (16{\%} ± 10{\%} vs 18{\%} ± 10{\%}), isovolumic relaxation time (29 ± 22 ms vs 36 ± 27 ms), and E/A ratio (2.7 ± 1.6 vs 3.3 ± 2.9) did not differ between cachectic and noncachectic patients (all P > . 1). By analyzing changes in LV mass over time, we found an increase (>20{\%}) in 2 (11{\%}) cachectic and 14 (40{\%}) noncachectic patients and a decrease in LV mass (>20{\%}) in 9 (50{\%}) cachectic and 8 (23{\%}) noncachectic patients (x2 test, P <.05). Conclusions: Although no specific cardiac abnormality could be detected echocardiographically in cachectic patients compared with patients with noncachectic chronic heart failure in a cross-sectional study, over time a significant loss of LV mass (>20{\%}) occurs more frequently in patients with cardiac cachexia.",
author = "Florea, {Viorel G.} and Henein, {Michael Y.} and Mathias Rauchhaus and Veronika Koloczek and Rakesh Sharma and Wolfram Doehner and Poole-Wilson, {Philip A.} and Coats, {Andrew J S} and Anker, {Stefan D.}",
year = "2002",
doi = "10.1067/mhj.2002.123314",
language = "English",
volume = "144",
pages = "45--50",
journal = "American Heart Journal",
issn = "0002-8703",
publisher = "Mosby Inc.",
number = "1",

}

TY - JOUR

T1 - The cardiac component of cardiac cachexia

AU - Florea, Viorel G.

AU - Henein, Michael Y.

AU - Rauchhaus, Mathias

AU - Koloczek, Veronika

AU - Sharma, Rakesh

AU - Doehner, Wolfram

AU - Poole-Wilson, Philip A.

AU - Coats, Andrew J S

AU - Anker, Stefan D.

PY - 2002

Y1 - 2002

N2 - Background: Recent evidence suggests the importance of noncardiac mechanisms in the genesis of the syndrome of cardiac cachexia. This raises the question of the relative role of the heart itself in this syndrome. This study sought to assess the cardiac dimensions, mass, and function and changes in these parameters over time in patients with chronic heart failure with and without cachexia. Methods: Doppler echocardiography was performed in 28 patients with nonedematous weight loss (>7.5% over a period of >6 months) compared with 56 matched patients without weight loss in a ratio of 1:2 (age 71 ± 13 vs 67 ± 8 years, P = .07; New York Heart Association class 2.9 ± 0.7 vs 2.6 ± 0.6, P = .08). In 18 cachectic and 35 noncachectic patients with previous echocardiographic recordings, we analyzed the changes in left ventricular (LV) dimensions and mass over time. Results: Cardiac dimensions including LV diastolic (69 ± 9 mm vs 67 ± 13 mm) and systolic cavity diameter (58 ± 11 mm vs 55 ± 15 mm), LV mass (480 ± 180 g vs 495 ± 190 g), and LV systolic and diastolic function including fractional shortening (16% ± 10% vs 18% ± 10%), isovolumic relaxation time (29 ± 22 ms vs 36 ± 27 ms), and E/A ratio (2.7 ± 1.6 vs 3.3 ± 2.9) did not differ between cachectic and noncachectic patients (all P > . 1). By analyzing changes in LV mass over time, we found an increase (>20%) in 2 (11%) cachectic and 14 (40%) noncachectic patients and a decrease in LV mass (>20%) in 9 (50%) cachectic and 8 (23%) noncachectic patients (x2 test, P <.05). Conclusions: Although no specific cardiac abnormality could be detected echocardiographically in cachectic patients compared with patients with noncachectic chronic heart failure in a cross-sectional study, over time a significant loss of LV mass (>20%) occurs more frequently in patients with cardiac cachexia.

AB - Background: Recent evidence suggests the importance of noncardiac mechanisms in the genesis of the syndrome of cardiac cachexia. This raises the question of the relative role of the heart itself in this syndrome. This study sought to assess the cardiac dimensions, mass, and function and changes in these parameters over time in patients with chronic heart failure with and without cachexia. Methods: Doppler echocardiography was performed in 28 patients with nonedematous weight loss (>7.5% over a period of >6 months) compared with 56 matched patients without weight loss in a ratio of 1:2 (age 71 ± 13 vs 67 ± 8 years, P = .07; New York Heart Association class 2.9 ± 0.7 vs 2.6 ± 0.6, P = .08). In 18 cachectic and 35 noncachectic patients with previous echocardiographic recordings, we analyzed the changes in left ventricular (LV) dimensions and mass over time. Results: Cardiac dimensions including LV diastolic (69 ± 9 mm vs 67 ± 13 mm) and systolic cavity diameter (58 ± 11 mm vs 55 ± 15 mm), LV mass (480 ± 180 g vs 495 ± 190 g), and LV systolic and diastolic function including fractional shortening (16% ± 10% vs 18% ± 10%), isovolumic relaxation time (29 ± 22 ms vs 36 ± 27 ms), and E/A ratio (2.7 ± 1.6 vs 3.3 ± 2.9) did not differ between cachectic and noncachectic patients (all P > . 1). By analyzing changes in LV mass over time, we found an increase (>20%) in 2 (11%) cachectic and 14 (40%) noncachectic patients and a decrease in LV mass (>20%) in 9 (50%) cachectic and 8 (23%) noncachectic patients (x2 test, P <.05). Conclusions: Although no specific cardiac abnormality could be detected echocardiographically in cachectic patients compared with patients with noncachectic chronic heart failure in a cross-sectional study, over time a significant loss of LV mass (>20%) occurs more frequently in patients with cardiac cachexia.

UR - http://www.scopus.com/inward/record.url?scp=0036308682&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036308682&partnerID=8YFLogxK

U2 - 10.1067/mhj.2002.123314

DO - 10.1067/mhj.2002.123314

M3 - Article

C2 - 12094187

AN - SCOPUS:0036308682

VL - 144

SP - 45

EP - 50

JO - American Heart Journal

JF - American Heart Journal

SN - 0002-8703

IS - 1

ER -